AMCIL Limited (AMH) Earnings Call Transcript & Summary
January 30, 2024
Earnings Call Speaker Segments
Operator
operatorGood day, and thank you for joining us for the AMCIL Half Year Financial Results Briefing. <<operator_script>> At this point I'll pass things over to Mark Freeman, AMCIL's Managing Director. Thanks very much. Over to you.
Robert Freeman
executiveGood afternoon, everyone. My name is Mark Freeman, and I serve as CEO and Managing Director of AMCIL Limited. I also hold the role of Portfolio Manager at AMCIL. Thank you for joining this briefing on the half year results. First, I want to acknowledge the Traditional Owners and Custodians of all the lands on which we meet today, and to pay my respects to their Elders — past, present and emerging. With me on the webinar today are Jaye Guy from the investment team; Andrew Porter, our CFO; Matthew Rowe, our Company Secretary; and Geoff Driver, our General Manager of Business Development. Before we begin the presentation, a few housekeeping notes about the webinar. This briefing draws on material available on the company's website. If you are accessing the presentation via the webcast on your computer, the slides will advance automatically. Lastly, please note that after the presentation there will be time for questions and answers. You can submit a question through the webcast using the tab at the bottom of the screen. I'll now turn to Slide 2 of the presentation, the disclaimer. Just to be clear, we are here to discuss the company. We are not providing any advice as such. Then we will move on to the results for the half year, and I will hand over to Andrew Porter, our CFO, to take you through Slide 4.
Andrew J. Porter
executiveThank you, Mark, and good afternoon everyone. The half-year profit — that's the first box at top left — came in at $4.1 million, which matches last year. Revenue actually received, though, was lower. We saw that coming and mentioned it last year at the AGM and in various shareholder presentations. We had a strong expectation that the big resource companies such as BHP would cut their dividends. That's exactly what happened. At this point last year, AMCIL received $1.1 million in dividends from BHP. This year, the figure was $540,000. So that's a substantial gap. The main reason the profit held fairly steady comes down to 2 things: first, other companies raised their dividends, and second, there was a one-off cut in expenses, which I'll get to shortly. The interim dividend of one was kept at $0.01, unchanged from last year. Portfolio return was 11.7%, which beat the market's 8.3%. We'll go into that in more detail later. Over to the next column — share price return was 8.5%. That's an accumulation return again, so it takes in dividends reinvested plus franking.
Andrew J. Porter
executiveAnd as you can see, that fell short of the portfolio return and was just a bit above the ASX 200, in line with it, and that gap has widened the discount. And again, I'll get to that later. The management expense ratio — which expresses the cost of running the company as a percentage of the average portfolio value — came down to 0.46%, so $0.46 for every $100 invested. Now, this was talked about at last year's AGM when the MER was much higher. The performance, as I'm sure many shareholders will recall, lagged the market at the close of the prior financial year — not the portfolio movement over 5 and 10 years. That's the one that excludes tax and costs, but the others were below. So what happens there is the portion of staff incentives tied to AMCIL performance wasn't paid out, and it was refunded this year. So that's what led to that cost reduction and the lower MER. The main driver of the MER, of course, will be how the portfolio performs between now and the end of the year. But with other costs currently in line, if the portfolio stays as it is in December, which won't happen, we would expect the MER to be about 0.59%.
Andrew J. Porter
executiveThose figures are closer to what we've seen historically. At year-end, the portfolio stood at just under $370 million, which is up from $324 million the prior year. Moving to the next slide, the premium discount slide, you'll notice the discount widened a bit, to 13.1% from 9.9% at the end of June. That's the gap I mentioned earlier between the portfolio return and the shareholder return. A lot of LICs right now have gone to a discount or seen their discount get bigger. The market isn't something we can control, but we do believe it matters that shareholders and potential shareholders have the information to see whether they're buying or selling shares at a premium or a discount to their underlying value. With that, I'll hand it back to Mark.
Robert Freeman
executiveAll right, thank you, Andrew. Turning now to Slide 7 in the presentation, we have the portfolio's performance returns, and as Andrew mentioned, over 6 months the portfolio rose 11.7% versus 8.3% for the index. Those figures include franking, both for AMCIL's performance and for the index, so it's a like-for-like comparison. Then over 1 year, as you can see, we're up 21.2% while the index gained 14%. Other portfolios sit ahead of the benchmark across 5 years. Also worth noting that our performance figures come after all costs and tax. On 10 years we're just behind the index, though obviously the index has no tax or fees deducted from it. And just to point out, this includes franking only to the extent we've actually paid it out, and we still hold franking credits that haven't been paid out yet. So those are still to flow into our performance numbers. So again, to reiterate, Andrew, just the franking credits we haven't paid out yet.
Andrew J. Porter
executiveSo by the close of June, once that last special dividend had been paid, it came to roughly $0.055 in franked dividend that we were in a position to distribute. And EPS across those 6 months has come in at approximately slightly above 1%. So once the interim account is paid with that figure of around $0.055, you would anticipate the present level to hold fairly steady.
Robert Freeman
executiveAll right, thanks, Andrew. Now let's turn to Slide 8. I just want to remind investors of what AMCIL is all about. It's a concentrated portfolio. We're going after quality businesses. Our positions aren't set to match the index precisely. We do take index weights into account, but the aim at AMCIL is high conviction in the stocks we hold. There's alignment of interest. For a high conviction managed fund such as this, we see it as a reasonably low-cost vehicle. No performance fees apply, and with substantial equity ownership held by directors and staff, there's alignment with shareholders. We also strive for low turnover, and that makes it tax effective. Turnover for the half, I believe, came in at about 7%. And once more, looking across the industry, that would be regarded as fairly low turnover. And we take a long-term approach to investing. So on to Slide 9, which covers that investment approach in a bit more detail. We want to restate what we look for in the stocks we buy. We said we target high-quality companies. So what does that mean? We favour businesses with unique assets that are very difficult to replicate, or to put it another way, businesses holding a leadership position, or one that's developing.
Robert Freeman
executiveWe look for businesses whose competitive edge can last. We steer clear of firms exposed to outside forces they can't control that might upend operations. Strong, conservative balance sheets matter to us, and experience keeps proving it: when a company piles on excessive debt, the business can land in real difficulty, and the stock price certainly can too. We favor businesses whose earnings come in more steadily. People matter enormously. So we seek companies led by capable, driven managers who hold meaningful ownership stakes. And we like our holdings to show what we term positive operating trends in the business. We avoid companies facing major headwinds—whether those are industry problems or operational ones. Why does all this matter? What we've learned is that these traits produce competitive advantage over the long run, and that translates into a higher return on capital. Businesses earning high returns can put money back into themselves to fuel growth, win market share, and strengthen their leadership position even further, ultimately generating solid profit growth—and that is what creates value for shareholders. Once we spot such companies, we aim to purchase them at moments of long-term value. That's why we discuss at length spotting dislocations in share prices as chances to build our positions or bring in new names.
Robert Freeman
executiveAnd when companies begin to miss on those measures, we consider trimming or selling out, since that tends to result in weak returns. Moving to Slide 10. We simply wanted to point out that AMCIL is spread across a range of sectors. Clearly, looking at index weight, the ASX 200 is heavily weighted toward banks and resources. Our aim is a more even-handed approach to sector exposure. And when you break the businesses down by market capitalization, you can also see a fairly balanced distribution — under $5 billion, $5 billion to $15 billion, $15 billion to $50 billion, and over $50 billion. I'd note that our weighting in what are traditionally termed mid- and small-cap stocks is likely near 40%. For the index, it would be roughly 20%. So our exposure to mid- and small-caps is far greater. And large-caps make up about 60% for us, versus closer to 78% for the index. There have probably been times in the past when our mid- and small-cap exposure was higher. Still, we go where we find the strongest opportunities and the best investment criteria. If those show up in the larger mid- and larger-cap names, we're comfortable tilting the portfolio in that direction.
Robert Freeman
executiveI think what we've been trying to point out is that our weighting is spread a bit more evenly across those sectors than the index's is. Then if we go to Slide 7 (sic) Slide 11, there's some recent activity worth walking through, because it helps investors grasp how we invest. We exited 2 stocks. We've discussed at length our purchase of Medibank during their cyber event — we viewed that as a major dislocation in the share price. Our view was that this wouldn't be an event that harms the business over the long term. The stock met our criteria when it came to backhaul people, a strong balance sheet, high return on capital, and a sustainable business model. The area where we had some caution was long-term growth. That share price dislocation created an opportunity for us. And once the share price recovered, we exited that position. We still like the company. We watch it closely, but we achieved what we set out to achieve, so we exited. And since we're seeing some better opportunities, we exited our holding in FINEOS, which hasn't quite reached what we'd want in terms of profitability. It still has some mentioning characteristics — being an owner-driver, establishing a leadership position in what they do, and annuity-type revenue streams — but the lack of profitability means the financial strength isn't there for us.
Robert Freeman
executiveAnd like I mentioned, other opportunities came up, so we got out of that position. We trimmed a little as well. James Hardie has performed really well and it's a very big holding — we probably ought to have kept the portion we cut for a while longer. Still, it remains a sizable position in the portfolio. Woolworths strikes us as very expensive. Auckland Airport — as you'll recall, we built that up considerably during COVID when the stock sold off, and the share price has now made that back. There are also a few issues involving the regulator and similar matters, which we'd characterize as an external factor affecting the business. So we trimmed a little from it. We reduced Domino's as well. We sold roughly 1/4 of our position. Again, this ties back to the factors I mentioned earlier. The balance sheet isn't where we want it to be. Beyond that, we see the company facing meaningful operational headwinds. So on a couple of our factors, that concerns us and signals that we ought to cut back. We did so. Looking back, we probably should have sold a bit more, but we're glad we took some out of that stock.
Robert Freeman
executiveOn Westpac — we discussed earlier that we likely had a quality bias favoring NAB. So we added NAB into the portfolio, built up our stake, and that let us cut back on Westpac. Some Westpac shares remain in our holdings. We still see value in it. Management, in our view, appears increasingly stable and the company pays very strong franked dividends. Given where the valuation sits, we're comfortable continuing to hold a portion at this stage. As for Transurban, that's another very large position, and we used the chance simply to trim it. On the additions side, we'll revisit some of those soon — most of those acquisitions get covered over the following few slides, so we may circle back to them. But returning to the trimming: if you recall what we've done across roughly the last 12 months, as a reminder, we exited our positions in Iris, PEXA and Nanosonics, and we also reduced Domino's. The reason was failures against our process. Each of those stocks has dropped considerably since we sold. And that, again, probably just underscores our aim of funding future acquisitions.
Robert Freeman
executiveWhat tends to sell the most are always shares that don't quite meet our criteria. Some of those happened to carry high multiples. I'd say the trimming we've carried out on solid quality names, where maybe there wasn't a problem, hasn't been our top seller. So in order to keep advancing, quality remains the finest approach to managing the portfolio. Moving on to Slide 12, just touching on a few of those acquisitions, I'll have Jaye walk through 3 of the stocks currently held in the portfolio.
Jaye Guy
executiveThanks, Mark. Now, turning to Slide 12, we've laid out some specifics on 3 fresh positions that entered the portfolio over the half year. We realize these may not be household names, so we figured a little context around our thinking on these companies could be useful. Altium, Mineral Resources and Objective are businesses we've tracked and admired for a while, since they show many of the traits Mark described earlier in the presentation. Where Altium is concerned, it holds a key role worldwide in electronics as the top software provider for printed circuit board design. Printed circuit boards are an essential building block in most electronic devices. A world that keeps getting smarter and more connected through electronic devices is a favorable tailwind for Altium, and we can see the company gaining customers and share in a market that is expanding. Importantly, Altium is profitable even while fully expensing its sizable research and development spend. The management team is tightly aligned with shareholders, and the balance sheet is well positioned, with net cash of $200 million at the last result, which, in our view, offers meaningful optionality to reinvest back into the business at a high return on equity or inorganically.
Jaye Guy
executiveMineral Resources is a diversified resources company that operates across mining services, iron ore, and lithium. Its approach differs somewhat from that of other resource companies, because its core mining services business is integrated and delivers services to its own mining operations instead of outsourcing them, and it also offers that capability to outside customers. The company is led by founding CEO and substantial shareholder Chris Ellison. Chris has a strong record of creating value across a number of commodity cycles. Although we do expect share price volatility given the character of the underlying commodity markets to which Mineral Resources is exposed, over the medium to long term we are drawn to the quality of its Australian-based asset base, together with our agile management team and their sharp focus on returning invested capital in what can be a capital-intensive industry. And moving on to Objective. Objective supplies best-in-class software that lets local councils, governments, and regulated industries in Australia, New Zealand, and the United Kingdom digitize and operate more efficiently, transparently, and securely. Objective is led by founder and significant shareholder Tony Walls, who has not sold a single share since listing the business on the ASX over 20 years ago.
Jaye Guy
executiveObjective has shown it can grow profitably over time. We see substantial spending on research and development driven by products, and we expect that to underpin the company's growth going forward. Looking at financial strength, Objective holds a robust balance sheet with net cash above $72 million. The business enjoys exceptionally strong customer retention and recurring subscription revenue at appealing margins, and that produces a high level of consistency in earnings. I'll hand things back to Mark now so he can walk through more examples of how our investment approach works in practice.
Robert Freeman
executiveThanks, Jaye. Now turning to Slide 13, where we keep up our practice of walking shareholders through the stocks we've bought and the reasoning behind them. Here, we focused on hunting for price dislocations among established companies. With IDP, we addressed this during our previous shareholder update, when we discussed the opportunity we see in that business. The main risk with this stock, I'd say, is that it holds a leading position in English language testing worldwide, and even more significantly, in placing students into universities. Its global standing is strong, and what drew us in was the chance for the company to expand its market share. The worldwide business is highly fragmented, yet they occupy a leading position with under 10% market share. So in our view, there's a solid opportunity for growth over the long-term. The problems that have been weighing on the share price really fall under the heading of outside influence. That, then, is the stock's key risk. Certain matters sit beyond their control, such as government decisions capable of affecting the business. And that's precisely the moment when you take a close look at a stock like this, while that factor is at play. It keeps bringing bad news, so to speak.
Robert Freeman
executiveYet looking at the longer horizon, this company has existed for a while now. In our view it is a genuinely well-established business. And as it puts money back into technology before its rivals do, we believe it can take market share. So we now hold a position in this portfolio. Still, given the dangers from external forces, this will never become an oversized holding. ASX has definitely been unpopular. It has faced plenty of operational difficulties, yet we noticed the transaction they completed to swap out their <<inaudible>>. Essentially, they have picked a different system. That strikes us as a very tidy solution. And from our standpoint, this is the first occasion where you begin to notice encouraging developments coming from the company, and we expect to see more appealing valuations. So it is very much a stock that had fallen out of favor, though a business whose traits fit what we look for given its monopolistic character. Moving to the following slide, we increased our NAB stake somewhat. We saw value in it, along with solid franked dividends, capable management, and an appealing return on equity. It was therefore meeting our standards. So we built that up. And more lately, we added to our Woodside position.
Robert Freeman
executiveWoodside, in our view, is deeply out of favor right now. If you scan the market today and ask which sectors are disliked, lithium names have certainly been mirroring that, and so has Woodside. Investors have felt a lot of anxiety regarding the approvals system in Australia. Oil prices have been soft, and on top of that, perhaps the market was digesting all of that bad news — and another element people bring up is the possibility that Woodside merges with or acquires Santos, depending on your perspective. So each of these things has resulted in negative headlines around the stock. We are, in fact, beginning to spot some value there once more, since it pays attractive franked dividends, which appeal to us, so we have modestly increased our position. Moving along now to Slide 15. To recap a bit of the purchasing activity we have had. We topped up our stake in Macquarie Technology Group. That is yet another owner-driver company. The Tudehope brothers are at the helm of it. As a reminder for everybody, they are growing their data center operations in Sydney. They have in fact now been securing their approvals, and the share price is climbing fairly well. So that business has drawn our interest. They have maintained a very solid balance sheet, and we believe that project will prove a very good one for them.
Robert Freeman
executiveWe've already discussed Objective and Min Resources. With Gentrack, we increased our stake once more. Once again, the management team is highly passionate. Their offerings consist of software, or a suite of software products. Their customers are utilities around the world. So this is a global operation. All of their R&D gets expensed. Their balance sheet is very strong. So once more, these are the traits we favor, and they delivered a solid result. So we added to that position. As for IPD, we took part in a capital raise. This is a small holding. They distribute electrical products here in Australia. Since listing, they've performed very well, and both management and Board members hold substantial equity. So once again, it has the alignment we seek. In our view, that company currently sits in a bit of a sweet spot. So we established a position there, and it has worked out very well for us. We simply wanted to discuss what took place with health care stocks over the year. Once again, a significant dislocation in share price occurred. Health care stocks worldwide were sold off. Concerns surrounding the weight loss drugs appeared to hit every health care stock, regardless of whether weight loss was going to affect them or not. We observed this unfold in CSL and ResMed.
Robert Freeman
executiveWe already held a very substantial stake in CSL. We discussed increasing it further, yet our view was that the position was sufficient, though we definitely saw it as an opportunity. As for ResMed, we ended up adding a modest amount during that period of weakness in its share price. Both of those stocks have now largely bounced back. That illustrates how the process works when temporary negative headlines hit good quality companies, since in our view the long-term story for CSL and ResMed, those 2 companies, has not really altered. Then we discussed reducing holdings when valuations stop looking attractive. But as I mentioned, the most effective trimming happens in stocks whose valuations are elevated and which also have problems. As I noted, the heart of it lies in net wealth. Those businesses genuinely have no issues. Their positions have grown larger, but actually it would probably be preferable to keep holding those stocks, given the considerable long-term growth still ahead of them, though we don't get every call right. So turning to Slide 16, it provides a summary of the portfolio. We think about stocks in terms of growth companies.
Robert Freeman
executiveWe really like owning solid, dependable businesses. These are big, well-established firms that we believe are still capable of growing at a steady pace and that hold very strong positions in their markets. It pleases us to own stocks delivering attractive franked dividends when we're able to purchase them at favorable prices, and I mentioned Woodside and NAB earlier. Then there are the asset play companies — businesses we regard as simply undervalued on a fundamental basis, and Santos sits in that category. We usually hold a larger number in the growth company area, since a portion of these are smaller firms. That way your exposure and growth are spread over a wider set of businesses, while the stalwart companies are typically bigger, so you hold fewer of them. Now let's turn to the outlook, and after that we can open it up for questions — slide 18. The major shift during the year has been in how people expect inflation to behave, to the point where markets now anticipate inflation coming down and, in the end, interest rates declining. That has produced a powerful reaction from growth stocks, or quality stocks, where we hold exposure. So one could take the view that this expectation of falling interest rates is what has driven the strong results from quality companies.
Robert Freeman
executiveI believe that's one element of it. But another major driver, in my view, was the operating performance delivered by the majority of our holdings, which we observed around August with the full-year numbers, followed by updates during the AGM season. By and large, quality businesses turned in quality results. You'll always get an exception. And clearly, the Domino's update from the other day fell short, but the bulk of our other holdings kept delivering solid results, and that has likewise been a major influence on share prices. Because of that, though, the market looks quite fully valued to us right now. Value is becoming tougher to identify. We head into the February reporting season eager for updates, yet comfortable with how the portfolio is positioned today. We also still suspect that the interest rate increases we've seen will eventually hit the consumer, and consequently potentially earnings, which is another reason for some caution on our part. Even so, we remain of the view that our investment approach — concentrating on quality companies, exercising patience, and seeking to act and build positions when value appears — is the right one, and we hold ourselves to that standard.
Robert Freeman
executiveSupporting management teams that are aligned matters. In the end, over the long term, earnings growth is what drives share prices. And as ever, resilience comes from a strong balance sheet, which also shields you when interest rates rise. So with that, I hope what comes through is a consistent approach to how we run AMCIL and a solid grasp of what we're doing with the portfolio, and we're glad to take questions now.
Geoffrey Driver
executiveOkay, thank you, Mark. I’ll be handling the Q&A portion. I should note for shareholders and participants that questions can be submitted through the tab located at the bottom of your screen. Our first question is this: Andrew, I see something attached to the dividend now — was there a capital gain?
Andrew J. Porter
executiveThat's a fair question. This year, there wasn't one. No—but it does get me thinking that going forward, we probably ought to make a point of noting that whenever we put out that release. So I appreciate you raising it, but none occurred this year.
Geoffrey Driver
executiveDid the recent downgrade to Domino's earnings have any effect on AMCIL?
Robert Freeman
executiveOkay, so the position in the portfolio was on the smaller side, but obviously a 30% drop in the stock does have an effect. I think you'll see that the position was just over 1%. We're glad we trimmed a quarter of it, but I think you can do the math and figure out what the impact was. And more than anything, it probably just confirms that the process we follow — weak balance sheets are really a recipe for fairly volatile performance and, more often than not, underperformance.
Geoffrey Driver
executiveSo I have a couple of connected questions for you. What choices do we have for trying to narrow the discount to NTA—is this a matter of liquidity? And I suppose the other side of that question is: what steps are we taking to shrink the share price discount to NTA? Are we seeing that through buying shares back on the market, the DRP?
Robert Freeman
executiveYes, certainly. In my view, the most effective way to narrow the discount is steady strong results, along with making sure the market grasps your strategy. We've been moving along that path for a while now. A buyback is currently underway, though we're hesitant about it. Our focus is on expanding the business. To that end, having a bigger company — and a couple of years back we were beginning to run some more regular share purchase plans — is something we'd like to pursue further. We've discussed that a larger company could still invest in the positions we favor, and that would definitely serve us well. Should we see the discount widen sharply, that's something we could consider. But broadly speaking, what we observe is that repurchasing shares typically doesn't solve the issue. In my view, simply delivering more consistent results and educating the market about our strategy is likely the best approach.
Geoffrey Driver
executiveI believe that's correct, Mark—across the industry, we've really observed that for smaller companies in particular, repurchasing shares hasn't truly served as the cure-all for narrowing those discounts. Ultimately, it comes down to performance and dividends, and that's clearly what we're focused on. So, there's a question regarding Objective Corporation. Following steady results reported in financial year '23—that is, the higher earnings, excluding any gain from the objectionable change in accounting treatment for research and development—do you expect Objective to grow revenue and earnings in financial year '24?
Robert Freeman
executiveYes. So they’ve begun capitalizing a portion of their R&D, which is probably more in line with how the rest of the market does it, so we factor that in. When it comes to earnings growth, look, Objective really is a business. You do need to take a genuinely long-term view. You’ve seen this before—and with Objective, there can be stretches of investment and stretches when your profits don’t move much. But once the business gains traction and you begin landing some new customers and growth takes off, then you can get stretches of very strong growth. So we aren’t in it for what they’ll do over the coming year. What we see is that this business has all the characteristics that our experience tells us will lead to a long—a good long-term investment, though it may not happen in the next year, yet we’re confident that over the long-term, this business will be a good investment for us.
Geoffrey Driver
executiveThanks, Mark. So once more, I'd just ask everyone to send in any questions using the box at the bottom of the screen. Here's one: is there any transfer of securities out of the trading portfolio into the investment portfolio?
Andrew J. Porter
executiveThat's a really good question. At AMCIL, this situation is uncommon, though it does happen. If people want more detail, I'm happy to go into it as far as they'd like. But to keep our accounting and tax treatment clean, we sell shares once the team has identified a stock they view as a trade — one that's undervalued and that they want to exit for a fast gain. If later they conclude that it genuinely suits the AMCIL model over a longer horizon, we'll carry out a sale from the trading portfolio into the investment portfolio just as though it had gone through the market — the point being that we avoid muddying either the investment portfolio or the trading portfolio. I hope that makes sense.
Geoffrey Driver
executiveSomeone's asking whether we can provide some indication of what IPD cost to acquire, along with Objective, and how large the existing holdings are.
Robert Freeman
executiveYeah. So with these kinds of companies, we typically — well, we certainly are — they're probably positioned. They're definitely under 1%, and likely nearer to about 0.5%. Even so, we still believe we want a position in these businesses, because as they succeed and improve, you can get share price appreciation, but often we'll add to positions over time as we grow more comfortable with the business. On the price, we don't discuss the exact price, but I did mention in IPD that we brought it in through a capital raising. So the result of that is we've done very well out of it so far. And then we've talked about Objective being a new position in the portfolio, so that would suggest somewhere around the current share price, I guess, without putting a number on it.
Geoffrey Driver
executiveThanks, Mark. As for our perspective on Woolworths moving ahead—especially given the government inquiries currently under way—and also our take on gold companies, and whether AMCIL is likely to put money into those businesses.
Robert Freeman
executiveYes. As you can see, we continue to view Woolworths as a quality operator. There's no doubt about that, though we did puzzle over some of the multiples a little. I'm quite comfortable keeping our positions in companies where our criteria raise no concerns, even when they become somewhat expensive. If the outlook remains sound, we're glad to hold. But with Woolworths, since it's more of a stalwart with lower growth, that's the kind of business we're more likely to trim somewhat when it gets repriced, though we still regard it as a quality business, so it remains in the portfolio. Regarding some of the more recent activity, I suppose it's clear we want our business to be focused on running the business and running the company well. We'll be meeting with the company soon. So I suppose there are some questions I'm eager to discuss with management to ensure they're genuinely focused on the company and on making sure the operational side of the business is strong, and that's where we'd like the company's focus to be.
Geoffrey Driver
executiveThanks, Mark. I believe we have a few additional questions at this point. So I’d encourage participants to ask questions if they have any before we wrap up the presentation. So what are your thoughts on the banking sector right now? You’ve mentioned the holdings we have, but the share prices have obviously risen a reasonable amount, so what’s your thinking there?
Robert Freeman
executiveYes. Well, look, we believe banks are in a stronger position than they were, let's say, 5 years ago. Their capital positions are really strong. Many of them have exited what you'd call noncore businesses. We've seen ROE improve. Return on equity is really important. We want to be in companies that generate a good return on equity. So certainly, net cap, certainly CBA hitting the mark and now NAB are. That's why we've been keen to own those 2. I think what's underestimated in the banks is the value of the franking credit. So when you take the dividends, add the franking credits, they don't have to grow a lot for them to be a good sound investment. And this is a case where some of our more stalwart companies or sometimes our growth companies, where we can sell call options against our position to bring further income to that and certainly the banks would sit in that group. Yes, CBA is -- looks pretty fully priced to us, but it's still they produce good quality results and everyone has been talking about -- or certainly market for a long time that they're just too expensive, but they keep performing.
Robert Freeman
executiveWe have accumulated NAB and, as I mentioned, Westpac — the reason we stay with them is genuinely a valuation story. Financially, though, they are simply very strong. In fact, payout ratios right now are quite manageable, so we don't perceive much risk when it comes to the dividends. Australia's population growth remains robust. I suppose the sole headwind we observe is that we simply aren't anticipating much earnings growth. Take Westpac, for instance: the yield comes in at roughly 6% fully franked. Gross that up for franking credits and you land at close to 8.5%. Should they manage growth of just a couple of percent annually, that makes for a solid, sound investment. So this isn't a sector where we'd hold an index-type weighting, but the worth of the franking credits plus the chance to sell call options whenever they run means we ought to earn a pretty good return from them.
Geoffrey Driver
executiveThanks, Mark. So there's a question here about how we see insurance companies and businesses that insure broking operations in the market.
Robert Freeman
executiveYes. Well, look, insurers really put you through a roller-coaster ride. Actually, about a year ago, I thought IAG seemed to offer some good value, though we didn't put money in, and it has risen since, but it's simply difficult to feel comfortable about it. QBE has drawn more support lately, but it has already had a fairly strong run. So again, I looked at that one some time back, since there was potentially some value in it, but I didn't purchase it. Yet judging by where these stocks sit now, it's simply hard to gain confidence regarding the future and what -- and when it comes to the criteria that we seek, there might be chances later on to adopt more of a trading stance, but both IAG and QBE have enjoyed fairly strong runs in which you could truly discern deep value. And I believe that moment has gone, so probably more on the watch list, but I acknowledge that certainly QBE, the management team looks much better and the business looks much better than it did. And insurance brokers, look, they're quite solid businesses and Austbrokers has performed incredibly well. The market felt fairly wary about the acquisition they made in the U.K., but it has been a huge success.
Robert Freeman
executiveStill, those companies do generate fairly solid returns, so we do keep an eye on their businesses. That said, they've also performed quite well in the market already, so as things stand, they're probably not near the top of our watch list.
Geoffrey Driver
executiveRegarding AMCIL, do they hold any shares — are there still shares held? Starpharma has never been among our holdings, so that's the situation.
Robert Freeman
executiveI believe there might have been a point some time back, but no, I don't think Starpharma has been with us for quite a while now.
Geoffrey Driver
executiveThere's a question regarding performance. You had gone through a stretch where results lagged, and those have recently reversed. Did you make any small adjustment to how you reach decisions in order to get there? And if that's the case, do you feel confident that the underperformance now belongs to the past?
Robert Freeman
executiveWell, that's certainly our hope. What I mean is that we have a fairly disciplined method, and ideally you're picking up that same message consistently across these briefings, assuming you caught the last couple I've given. So we're taking a somewhat detailed look. I suppose performance appears fine over the past 12 months, yet we must stay focused on examining what has worked and what hasn't, and what we keep coming back to is that consistency with our process is the solution when we're generating those results. We've reviewed all the opportunities that might have been available to us through our approach—remaining with higher quality companies, ensuring we seize value when it appears, and filtering out lower quality stocks is another route for doing so. Thus, from a long-term view, I believe the frameworks are solid. We'll simply continue executing on it and won't deviate from this approach by moving into lower quality stocks at any point or turning away from what our frameworks indicate. That's where problems can arise. So to the degree you're able to have confidence—I can't predict what will occur over the next 12 months. But I can tell you that when we examine our portfolio, these are good companies.
Robert Freeman
executiveYou're always going to have a few that fail, but I think we've managed the risk well in the ones where issues did arise, or we've actually sold out of some positions. So we just need to stay the course and let how things perform over the long term play out. It comes back to what we've been doing for a long time — stay with quality.
Geoffrey Driver
executiveAndrew, you asked about the financing cost, and that's on Page 8 of the report we put out this morning — it shows $65,000 — but no loan appears on the balance sheet on Page 16, so.
Andrew J. Porter
executiveGood question. It's actually shown on Page 14 of this morning's release, and it does show finance cost of $65,000. There are 2 components to those finance costs. First, there are the insurance type costs you pay for simply having a line available for when you need it. So that's part of it. And the cash flow statement, which appears later in the results, will show that we did actually draw down on that line during the year and then repay it. That's why we paid for it. So it is there when we do need it, so we don't have to sell shares when we see an opportunity in the market that comes with the cost, and during the period when we did have that loan there were also interest costs attached to it. So those 2 together make up that finance cost.
Geoffrey Driver
executiveThanks, Andrew. With the recent reports about the Brazilian court's decision to fine BHP a substantial amount over the dam disaster from a few years back, we'd be keen to hear your perspective on the financial consequences — specifically, what this means for BHP's capacity to keep paying an attractive dividend going forward.
Robert Freeman
executiveWhat I'd say is that problems of this kind have a habit of coming back to trouble big mining firms, and that's been true for many decades, yet what consistently comes through is how good the underlying assets are and the cash flow those assets generate. So they clearly have the wherewithal to ride out these troubles. Over the long run, then, I don't believe there will be a lasting effect on how much the company can pay out in dividends. Its balance sheet is very strong and it is generating solid profits. I'd argue the bigger question is what happens with the iron ore price. Right now we don't hold Rio. We have more in -- we hold BHP since we like its copper assets and the output coming from them. At bottom, those assets are so good, and the long-term cash flows, I believe, justify continuing to invest in the company.
Geoffrey Driver
executiveAre we keeping any of the newly issued Suncorp stock?
Robert Freeman
executiveNot right now. The stock has performed fairly decently. That said, we've noted this is a business at a more mature stage, and our attention sits elsewhere.
Geoffrey Driver
executivePWH is likewise an owner-driver business with a strong track record — has it come up in our review?
Robert Freeman
executiveYeah, we have examined it, and we keep examining it. Among those small-cap stocks, it's one that carries fairly rich valuations. So it's just something we'll keep tracking. On our investment team, we have people who concentrate on small stocks. So it's definitely on our radar to watch, though we would want the share price somewhat lower than it stands now before we buy.
Geoffrey Driver
executiveOne more question coming back to Domino's pizzas — given the investment process, is it your preference to exit that company?
Robert Freeman
executiveYes. Look, this is a case that meets the bar we set for an owner-driver business. There have definitely been some stumbles across the past couple of years, but over the long term the CEO has built quite a lot of value. That said, you always need to keep testing management to see whether they can keep running the business. So that has certainly been a challenge for us. The stock has fallen by now. There's likely a decent amount of bad news potentially baked into the price. We're probably going to hold a bit longer. We'll look at how the business is doing during reporting season, but again, it just highlights the framework we're saying — we should hold less. We did reduce, but the frameworks were probably saying we should have exited really. So — and it really comes down to that balance sheet issue. If the company had a much stronger balance sheet, we'd probably be more comfortable holding the position, because it gives the company the ability to, I guess, reset the business, give franchisees a bit more time to make better profits. But when you got — when you're stretched on debt, there's so much focus on producing results for the now, and that puts stress on the business overall.
Robert Freeman
executiveThe chance they have in Germany is something we find appealing, and that has always been attractive to us. However, the parts where they ran into some difficulty with Japan simply aren't paying off for them, and they borrowed money to expand into Asia, which in my mind definitely raised some doubts. So, look, I believe we need to keep reevaluating it, and unless we observe those traits getting better, they could catch some operational tailwinds and there's a route to strengthening the balance sheet. I think it will keep challenging us regarding whether we ought to hold the stock or not.
Geoffrey Driver
executiveThere's a related question about how you see things being valued at this point.
Robert Freeman
executiveYeah, I mean, when you look at the PE, it does look better. The EBIT and EBITDA multiple seems more reasonable, but it's really the characteristics that matter to us. So until we can truly get a handle on things, I need to develop a bit of a feel myself, within the company, for where they stand on that balance sheet beforehand. It appears better valued than it has ever been. But obviously, there's this: the company never had the balance sheet risks it has now.
Geoffrey Driver
executiveThanks, Mark. So once more, since we’re nearing the end of the session, I’d encourage anyone who’d like to ask a question to please do so within roughly the next minute. I have a question here: if you want to grow the company, how about doing a share purchase...
Robert Freeman
executiveYes. Well, that's a step we'd be interested in taking. I suppose what's always tricky on our side is timing these things so they're equitable for all involved — both the people who participate and those who don't. And with the share price discount, we'd need to provide something at a pretty substantial markdown relative to the market. Then there's a bit of a question about whether that would be equitable for the ones who stay out. So I'd say our priority is delivering solid results and, in time, hopefully having the chance to run additional share purchase plans.
Geoffrey Driver
executiveDo you have any interest in businesses centered on lithium or copper, or are you content with BHP as a corporation?
Robert Freeman
executiveYeah. Well, look, BHP is the quality player these days. I mean, OZ Minerals was clearly acquired by BHP. And we want exposure to the bigger, more established businesses, so we're happy with BHP. I mean, BHP secured the world-class, low-cost assets. And that's really what our frameworks are designed for. And in lithium, we obviously gain exposure through Mineral Resources, and that's the one we're focused on because of the owner-driver attributes it has. And even more recently, I think we saw some of the -- a lot of the mining companies had somewhat disappointing quarterly updates, and Min Resources is one that actually delivered a good quality quarterly update. And we kind of attribute that to the fact that it comes approved and they're just really good at running mines. And then -- yes, and so -- but Min gives us exposure to lithium.
Geoffrey Driver
executiveThanks, Mark. Is there any view we can offer on travel-related names, such as Corporate Travel?
Robert Freeman
executiveWe continue to monitor both of them since each possesses the owner-driver traits we favor. The executives in charge, and the CEO in particular, clearly understand their companies, because in both instances these are the individuals who have steadily built them. Still, these are sectors that can, once again, be buffeted by outside forces. Corporate Travel has assembled a very robust business. That one is probably the name we have examined most, especially as it has expanded abroad. The industry is highly fragmented. We had some curiosity about how they are faring in the U.S., since they have made a few acquisitions there. That market is far more fragmented than Australia. A solid proposition exists, yet they are heavily tied to economic cycles. So these are likely stocks that remain on the periphery, with certain traits we appreciate, but we would continue to watch them.
Geoffrey Driver
executiveI have a couple of follow-up remarks regarding the banking sector, specifically about Bendigo Bank and Bank of Queensland. Are there any investment opportunities they provide? And besides that, could there be potential for rationalization in banking at these firms, since scale is clearly an issue when it comes to competing in banking nowadays?
Robert Freeman
executiveYes, that's correct. And yes, that is genuinely what has come through. So our attention has really been on the majors. And for exactly that reason, the regional banks simply have not generated the returns, especially return on equity, that the majors have generated, and they just lack the scale. So therefore, under our frameworks, at present, Bendigo and Bank of Queensland don't meet, I suppose, the frameworks that we're looking for. And we're seeing that in their results over the long term. CBA and NAB have delivered better quality results, particularly CBA.
Geoffrey Driver
executiveI'll make this the final question. I realize a number of participants are staying on and will drop off a bit. So is there any plan to merge AMCIL and Mirrabooka, given that Mirrabooka fits into the small space that, I suppose, is the small space in terms of small company stocks that AMCIL holds — could that be a way to grow the fund?
Robert Freeman
executiveYes. No, what I mean by that is that these are two separate companies. Each has its own independent Board of Directors. They form their own views about how the business should be operated. So both have their own investment objectives that they are working toward. Mirrabooka is really focused on just small-cap stocks. It's probably about 50 to 60 stocks. AMCIL is about trying to pick the eyes out of the market when it comes to small, mid or large, and they run a much more concentrated portfolio. Something — we prefer something around mid-30s. In terms of number of stocks, that probably pushed towards 40%. So there's an opportunity to reduce the number of stocks. So slightly different approaches. And I think each Board will probably believe there's a place for the style of fund they're running within the market they operate in.
Geoffrey Driver
executiveWe'll make this the final one—we wanted a couple of questions, so maybe the last 2 questions. So how does Treasury Wine Estates look to us?
Robert Freeman
executiveYeah. Well, we continue to monitor Treasury. Clearly, through its Penfolds brand, it holds a very strong position. It has certain traits that appeal to us, but wine remains an extremely competitive sector. When China pulled back, they certainly performed well selling their products into Asia. On that front, they did a solid job. They've made a U.S. acquisition recently. Well, it's a business we're watching, yet the industry is just highly competitive. So measured against our framework, it probably comes up a bit short. That said, at the right price, we wouldn't necessarily rule it out. Management, in our view, is very strong. And I notice there's a question regarding JB Hi-Fi.
Geoffrey Driver
executiveAbsolutely, let me cover the retail numbers.
Robert Freeman
executiveYeah, well, that definitely meets the standards we set, no question. It's a name we're monitoring. Things were getting interesting when it dropped into the low-40s, and we came close to picking up some shares. But clearly the stock has performed very well, though it does hold that leading position in the market. It offers a very solid return on capital, a strong balance sheet, and it's well managed. So it satisfies every requirement on our list. We'll be certain to acquire it at the next chance we get, and it pays great frank dividends too. So look, that's one we may have missed earlier in the year.
Geoffrey Driver
executiveAppreciate that, Mark. I believe we'll finish up at this point. So I'll turn things back over to you to close out the meeting.
Robert Freeman
executiveAll right, and thank you all for being here on this call. Holding ourselves answerable to shareholders is a key element of how we operate. As I've mentioned previously, my hope is that by tuning into these sessions over time, you'll notice a steady pattern in what we tell you and in how we go about things — and ideally, across the long run, that produces steady feedback too. So as a reminder to shareholders: shareholder information meetings are set for March, and we'll be visiting every capital city, so keep an eye out for those. If you'd like to meet us or pose questions, please come along. The following webinar of this kind will accompany the full year results in July, and the AGM in October is going to be webcast. That gives you, I suppose, 4 points of contact across the year to learn how things are going at AMCIL. With that, thanks for attending.
Operator
operatorThat brings us to the end of today's conference call. We appreciate everyone joining us. You can go ahead and disconnect your lines at this time.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete AMCIL Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to AMCIL Limited earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AMCIL Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.